Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04511338 · ClinicalTrials.gov registry record · NA
Feasibility Study for Heparin-free Hemodialysis With the Dialyzer With Endexo™
A NA study, sponsored by Fresenius Medical Care North America.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT04511338 is a NA study that has completed, run by Fresenius Medical Care North America. The registered enrollment target is 16 participants.
The verdict
NCT04511338, a NA study, has completed, sponsored by Fresenius Medical Care North America.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study will assess the safety and efficacy of heparin free hemodialysis (HD) performed with dialyzers with Endexo in adult end-stage renal disease (ESRD) subjects on thrice-weekly in-center HD.
Interventions
- DEVICE Dialyzer with Endexo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2021-06-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04511338
The ClinicalTrials.gov registry entry for NCT04511338 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fresenius Medical Care North America, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dialyzer with Endexo is the first listed.
NCT04511338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04511338 about?
NCT04511338 is a clinical study titled "Feasibility Study for Heparin-free Hemodialysis With the Dialyzer With Endexo™". This study will assess the safety and efficacy of heparin free hemodialysis (HD) performed with dialyzers with Endexo in adult end-stage renal disease (ESRD) subjects on thrice-weekly in-center HD.
What is the current status of trial NCT04511338?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2020-11-02. Estimated completion is 2021-06-16.
What interventions are being tested in trial NCT04511338?
The interventions under investigation include: Dialyzer with Endexo (DEVICE).
Who is sponsoring clinical trial NCT04511338?
This trial is sponsored by Fresenius Medical Care North America, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.